1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Human Rabies Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Vero Cell
  • 1.3.3 BHK
  • 1.3.4 Chick Embryo Cell
  • 1.3.5 Human Diploid Cells
  • 1.3.6 Others
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Human Rabies Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Pre-exposure
  • 1.4.3 Post-exposure
• 1.5 Global Human Rabies Vaccination Market Size & Forecast
  • 1.5.1 Global Human Rabies Vaccination Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global Human Rabies Vaccination Sales Quantity (2020-2031)
  • 1.5.3 Global Human Rabies Vaccination Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 Bharat Biotech
  • 2.1.1 Bharat Biotech Details
  • 2.1.2 Bharat Biotech Major Business
  • 2.1.3 Bharat Biotech Human Rabies Vaccination Product and Services
  • 2.1.4 Bharat Biotech Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Bharat Biotech Recent Developments/Updates
• 2.2 Bavarian Nordic
  • 2.2.1 Bavarian Nordic Details
  • 2.2.2 Bavarian Nordic Major Business
  • 2.2.3 Bavarian Nordic Human Rabies Vaccination Product and Services
  • 2.2.4 Bavarian Nordic Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Bavarian Nordic Recent Developments/Updates
• 2.3 Sanofi-Pasteur
  • 2.3.1 Sanofi-Pasteur Details
  • 2.3.2 Sanofi-Pasteur Major Business
  • 2.3.3 Sanofi-Pasteur Human Rabies Vaccination Product and Services
  • 2.3.4 Sanofi-Pasteur Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Sanofi-Pasteur Recent Developments/Updates
• 2.4 Chengda Bio
  • 2.4.1 Chengda Bio Details
  • 2.4.2 Chengda Bio Major Business
  • 2.4.3 Chengda Bio Human Rabies Vaccination Product and Services
  • 2.4.4 Chengda Bio Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Chengda Bio Recent Developments/Updates
• 2.5 KANGH
  • 2.5.1 KANGH Details
  • 2.5.2 KANGH Major Business
  • 2.5.3 KANGH Human Rabies Vaccination Product and Services
  • 2.5.4 KANGH Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 KANGH Recent Developments/Updates
• 2.6 Prcmise
  • 2.6.1 Prcmise Details
  • 2.6.2 Prcmise Major Business
  • 2.6.3 Prcmise Human Rabies Vaccination Product and Services
  • 2.6.4 Prcmise Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Prcmise Recent Developments/Updates
• 2.7 Henan Grand Biopharma
  • 2.7.1 Henan Grand Biopharma Details
  • 2.7.2 Henan Grand Biopharma Major Business
  • 2.7.3 Henan Grand Biopharma Human Rabies Vaccination Product and Services
  • 2.7.4 Henan Grand Biopharma Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Henan Grand Biopharma Recent Developments/Updates
• 2.8 Zhuoyi Biological
  • 2.8.1 Zhuoyi Biological Details
  • 2.8.2 Zhuoyi Biological Major Business
  • 2.8.3 Zhuoyi Biological Human Rabies Vaccination Product and Services
  • 2.8.4 Zhuoyi Biological Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Zhuoyi Biological Recent Developments/Updates
• 2.9 ZhongKe Biopharm
  • 2.9.1 ZhongKe Biopharm Details
  • 2.9.2 ZhongKe Biopharm Major Business
  • 2.9.3 ZhongKe Biopharm Human Rabies Vaccination Product and Services
  • 2.9.4 ZhongKe Biopharm Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 ZhongKe Biopharm Recent Developments/Updates
• 2.10 Ningbo Rongan Biological
  • 2.10.1 Ningbo Rongan Biological Details
  • 2.10.2 Ningbo Rongan Biological Major Business
  • 2.10.3 Ningbo Rongan Biological Human Rabies Vaccination Product and Services
  • 2.10.4 Ningbo Rongan Biological Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Ningbo Rongan Biological Recent Developments/Updates
• 2.11 Indian Immunologicals
  • 2.11.1 Indian Immunologicals Details
  • 2.11.2 Indian Immunologicals Major Business
  • 2.11.3 Indian Immunologicals Human Rabies Vaccination Product and Services
  • 2.11.4 Indian Immunologicals Human Rabies Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 Indian Immunologicals Recent Developments/Updates

3 Competitive Environment: Human Rabies Vaccination by Manufacturer

• 3.1 Global Human Rabies Vaccination Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global Human Rabies Vaccination Revenue by Manufacturer (2020-2025)
• 3.3 Global Human Rabies Vaccination Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of Human Rabies Vaccination by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 Human Rabies Vaccination Manufacturer Market Share in 2024
  • 3.4.3 Top 6 Human Rabies Vaccination Manufacturer Market Share in 2024
• 3.5 Human Rabies Vaccination Market: Overall Company Footprint Analysis
  • 3.5.1 Human Rabies Vaccination Market: Region Footprint
  • 3.5.2 Human Rabies Vaccination Market: Company Product Type Footprint
  • 3.5.3 Human Rabies Vaccination Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Human Rabies Vaccination Market Size by Region
  • 4.1.1 Global Human Rabies Vaccination Sales Quantity by Region (2020-2031)
  • 4.1.2 Global Human Rabies Vaccination Consumption Value by Region (2020-2031)
  • 4.1.3 Global Human Rabies Vaccination Average Price by Region (2020-2031)
• 4.2 North America Human Rabies Vaccination Consumption Value (2020-2031)
• 4.3 Europe Human Rabies Vaccination Consumption Value (2020-2031)
• 4.4 Asia-Pacific Human Rabies Vaccination Consumption Value (2020-2031)
• 4.5 South America Human Rabies Vaccination Consumption Value (2020-2031)
• 4.6 Middle East & Africa Human Rabies Vaccination Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global Human Rabies Vaccination Sales Quantity by Type (2020-2031)
• 5.2 Global Human Rabies Vaccination Consumption Value by Type (2020-2031)
• 5.3 Global Human Rabies Vaccination Average Price by Type (2020-2031)

6 Market Segment by Application

• 6.1 Global Human Rabies Vaccination Sales Quantity by Application (2020-2031)
• 6.2 Global Human Rabies Vaccination Consumption Value by Application (2020-2031)
• 6.3 Global Human Rabies Vaccination Average Price by Application (2020-2031)

7 North America

• 7.1 North America Human Rabies Vaccination Sales Quantity by Type (2020-2031)
• 7.2 North America Human Rabies Vaccination Sales Quantity by Application (2020-2031)
• 7.3 North America Human Rabies Vaccination Market Size by Country
  • 7.3.1 North America Human Rabies Vaccination Sales Quantity by Country (2020-2031)
  • 7.3.2 North America Human Rabies Vaccination Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe Human Rabies Vaccination Sales Quantity by Type (2020-2031)
• 8.2 Europe Human Rabies Vaccination Sales Quantity by Application (2020-2031)
• 8.3 Europe Human Rabies Vaccination Market Size by Country
  • 8.3.1 Europe Human Rabies Vaccination Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe Human Rabies Vaccination Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific Human Rabies Vaccination Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific Human Rabies Vaccination Sales Quantity by Application (2020-2031)
• 9.3 Asia-Pacific Human Rabies Vaccination Market Size by Region
  • 9.3.1 Asia-Pacific Human Rabies Vaccination Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific Human Rabies Vaccination Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America Human Rabies Vaccination Sales Quantity by Type (2020-2031)
• 10.2 South America Human Rabies Vaccination Sales Quantity by Application (2020-2031)
• 10.3 South America Human Rabies Vaccination Market Size by Country
  • 10.3.1 South America Human Rabies Vaccination Sales Quantity by Country (2020-2031)
  • 10.3.2 South America Human Rabies Vaccination Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa Human Rabies Vaccination Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa Human Rabies Vaccination Sales Quantity by Application (2020-2031)
• 11.3 Middle East & Africa Human Rabies Vaccination Market Size by Country
  • 11.3.1 Middle East & Africa Human Rabies Vaccination Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa Human Rabies Vaccination Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 Human Rabies Vaccination Market Drivers
• 12.2 Human Rabies Vaccination Market Restraints
• 12.3 Human Rabies Vaccination Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Human Rabies Vaccination and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Human Rabies Vaccination
• 13.3 Human Rabies Vaccination Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Human Rabies Vaccination Typical Distributors
• 14.3 Human Rabies Vaccination Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Human Rabies Vaccination market size was valued at US$ 1237 million in 2024 and is forecast to a readjusted size of USD 1644 million by 2031 with a CAGR of 4.2% during review period.
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Human Rabies Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Rabies Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Rabies Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Rabies Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Rabies Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Rabies Vaccination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Rabies Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Rabies Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Market segment by Application
Pre-exposure
Post-exposure
Major players covered
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Rabies Vaccination, with price, sales quantity, revenue, and global market share of Human Rabies Vaccination from 2020 to 2025.
Chapter 3, the Human Rabies Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Rabies Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rabies Vaccination.
Chapter 14 and 15, to describe Human Rabies Vaccination sales channel, distributors, customers, research findings and conclusion.